games

Approval Within 24 Hours
We are shifting DB. Members may see some problems

Search:

Alzheimers News's Articles in Infectious Diseases

  • Risk Of Alzheimer's Disease May Be Reduced By Juices
    In a large epidemiological study, researchers found that people who drank three or more servings of fruit and vegetable juices per week had a 76 percent lower risk of developing Alzheimer's disease than those who drank juice less than once per week.
  • Memory Clinics Are Diverting NHS Resources From High Quality Care
    Specialist memory clinics for patients with dementia are taking NHS resources away from long term integrated care, warn senior doctors in this week's BMJ.

    Since 2001, the National Institute for Health and Clinical Excellence (NICE) has recommended that cholinesterase inhibitors should be available to people with mild to moderate Alzheimer's disease, writes consultant psychiatrist, Anthony Pelosi and colleagues.
  • Juices May Reduce Alzheimer's Disease Risk
    In a large epidemiological study, researchers found that people who drank three or more servings of fruit and vegetable juices per week had a 76 percent lower risk of developing Alzheimer's disease than those who drank juice less than once per week.
  • Vegetable And Fruit Juice Consumption Lower Alzheimer's Risk
    If you drink fruit and/or vegetable juice at least three times a week you could be reducing your chances of developing Alzheimer's disease (AD) by 76%, say scientists in a new study. Even if you have a fruit and/or vegetable juice just twice a week your risk goes down 16%.
  • Columbia Researchers Restore Memory Lost In Mice With Alzheimer's
    Researchers at Columbia University Medical Center have successfully restored normal memory and synaptic function in mice suffering from Alzheimer's disease. The study was published today on the website of the journal Cell.
  • Brain Enzyme Treatment Relieves Memory Lapse In Alzheimer's Mice
    An enzyme that helps neurons rid themselves of excess or aberrant proteins is required for normal brain function, according to a new report in the August 25, 2006 issue of the journal Cell, published by Cell Press. What's more, by increasing brain levels of the enzyme in mice with Alzheimer's symptoms, the researchers found they could reverse lapses of memory characteristic of the debilitating disease.
  • IOS Press Presents Commemorative Volume On Alzheimer's Disease To Her Majesty, Queen Sofia Of Spain
    During the recent International Conference on Alzheimer's Disease and Related Disorders (ICAD), IOS Press was honored to present Queen Sofia of Spain with a commemorative edition of Alzheimer's Disease: A Century of Scientific and Clinical Research. This landmark work commemorates the centennial of Alois Alzheimer's discovery of what would be known as Alzheimer's disease (AD). Each conference participant received a copy of the book with the compliments of GlaxoSmithKline.
  • Myriad Genetics Completes Enrollment In U.S. Phase 3 Clinical Trial Of Flurizan For Alzheimer's
    Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has completed enrollment in its U.S. Phase 3 clinical trial of Flurizan(TM) for patients with Alzheimer's disease.
  • Scientists Closer To Early Alzheimer's Diagnosis
    A painless skin test for Alzheimer's disease? It may seem unlikely, but scientists at the Blanchette Rockefeller Neurosciences Institute (BRNI) have isolated a substance in skin cells that may provide doctors with a quick and accurate yes-or-no answer when they suspect a patient is showing early signs of the disease. The test could be performed easily by a nurse or medical technician in a doctor's office or outpatient clinic.
  • A “Leaky” Blood-Brain Barrier And Alzheimer's
    Alzheimer's disease (AD) affects 4.5 million Americans according to the National Institutes of Aging; the direct and indirect costs of the disease exceed $100 billion each year. As the wave of baby boomers continues to age it is apparent that the number of people with AD will increase, along with the costs for care. While no one knows the precise underlying cause leading to the characteristic pathology of the disease.

| |

севастополь

Powered by Article Dashboard